BIOMAT Database Logo BIOMAT Database Logo

Susceptibility of Mycobacterium fallax to imipenem and twenty other antimicrobial agents. 1984

H Haas, and R Zubi, and T G Sacks

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009161 Mycobacterium A genus of gram-positive, aerobic bacteria. Most species are free-living in soil and water, but the major habitat for some is the diseased tissue of warm-blooded hosts. Mycobacteria
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013845 Thienamycins Beta-lactam antibiotics that differ from PENICILLINS in having the thiazolidine sulfur atom replaced by carbon, the sulfur then becoming the first atom in the side chain. They are unstable chemically, but have a very broad antibacterial spectrum. Thienamycin and its more stable derivatives are proposed for use in combinations with enzyme inhibitors. Antibiotics, Thienamycin,Thienamycin Antibiotics
D015378 Imipenem Semisynthetic thienamycin that has a wide spectrum of antibacterial activity against gram-negative and gram-positive aerobic and anaerobic bacteria, including many multiresistant strains. It is stable to beta-lactamases. Clinical studies have demonstrated high efficacy in the treatment of infections of various body systems. Its effectiveness is enhanced when it is administered in combination with CILASTATIN, a renal dipeptidase inhibitor. Imipemide,N-Formimidoylthienamycin,Imipenem Anhydrous,Imipenem, Anhydrous,MK-0787,MK0787,Anhydrous Imipenem,Anhydrous, Imipenem,MK 0787,N Formimidoylthienamycin

Related Publications

H Haas, and R Zubi, and T G Sacks
In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents.
August 1987, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
H Haas, and R Zubi, and T G Sacks
Susceptibility of Legionella pneumophila to twenty antimicrobial agents.
September 1980, Antimicrobial agents and chemotherapy,
H Haas, and R Zubi, and T G Sacks
Susceptibility of 114 isolates of the Bacteroides fragilis group to imipenem and eight other antimicrobial agents.
July 1988, Pathology,
H Haas, and R Zubi, and T G Sacks
Susceptibility of Campylobacter fetus to twenty-two antimicrobial agents.
March 1978, Antimicrobial agents and chemotherapy,
H Haas, and R Zubi, and T G Sacks
Susceptibility of Campylobacter jejuni to twenty-three antimicrobial agents.
January 1983, Pathology,
H Haas, and R Zubi, and T G Sacks
In vitro susceptibility of Mycobacterium marinum to dihydromycoplanecin A and ten other antimicrobial agents.
June 1990, The Journal of dermatology,
H Haas, and R Zubi, and T G Sacks
Susceptibility of organisms in the Mycobacterium fortuitum complex to antituberculous and other antimicrobial agents.
August 1977, Antimicrobial agents and chemotherapy,
H Haas, and R Zubi, and T G Sacks
Corynebacterium equi: in vitro susceptibility to twenty-six antimicrobial agents.
December 1980, Antimicrobial agents and chemotherapy,
H Haas, and R Zubi, and T G Sacks
Susceptibility of Campylobacter fetus subsp. jejuni to twenty-nine antimicrobial agents.
October 1978, Antimicrobial agents and chemotherapy,
H Haas, and R Zubi, and T G Sacks
In vitro susceptibility of "Campylobacter upsaliensis" to twenty-four antimicrobial agents.
November 1990, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
Copied contents to your clipboard!